HNRNPA2B1 and Miyoshi myopathy: This study highlights that HNRNPA2B1 mediates increased AKT3 expression by enhancing m6A‐dependent ILF3 mRNA stability, thus playing a critical role in MM progression and correlating with poor prognosis274 (Figure 7).